-transparent.png){kind=logo}
This article reviews the literature on possible growth-suppressing effects of stimulant medications in the long-term treatment of children with the hyperkinetic behavior syndrome. The evidence clearly indicates a temporary retardation in the rate of growth in weight and suggests a temporary slowing of growth in stature, but no effect on adult stature or weight. This temporary effect on growth is present during the first few years of treatment and seems related to drug dosage and to the presence or absence of drug holidays. These conclusions related specifically to treatment during the prepubertal period; little is known of the growth-related effects of treatment extending through pubescence.
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
April 1977,
Psychopharmacology bulletin,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
April 1976,
Psychopharmacology bulletin,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
January 1975,
The American journal of orthopsychiatry,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
April 1975,
Pediatrics,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
January 1976,
Drugs,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
April 1991,
Journal of learning disabilities,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
August 1976,
Pediatrics,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
April 1977,
Psychopharmacology bulletin,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
June 2005,
Clinical pediatrics,
A F Roche, and
R S Lipman, and
J E Overall, and
W Hung
March 2020,
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent,
